Research conducted in mice has revealed that ‘resetting’ immune cells could improve recovery following traumatic brain injury, even months after the injury has occurred.
Using stem cell-derived BrainSpheres, also known as ‘mini-brains’, researchers have detected harmful side effects of a common antidepressant drug on the developing brain. This novel model for drug testing could provide a good alternative to traditional animal testing.
Machine-learning techniques have identified variability among the brain networks of children, which could help inform personalized treatments for psychiatric disorders.
Take a peek behind the scenes of a recently published study in the journal Nanomedicine as we ask first author, Filippo Rossi (Politecnico di Milano, Italy), about the challenges in moving nanovector-based therapies into the clinic for spinal cord injuries.
Take a look behind the scenes of a recent Review paper from Neurodegenerative Disease Management as we ask first author, Jiwon Oh (University of Toronto, Canada), about the diagnostic and management issues surrounding progressive multiple sclerosis.
In this research article from the Journal of Comparative Effectiveness Research, the authors assess the real-world outcomes among patients with Duchenne muscular dystrophy receiving deflazacort or prednisone in real-world practice.